Add BrightSurf on Google Email

A possible therapeutic approach to COVID-19

The article suggests a potential treatment option for COVID-19 by targeting SARS-CoV-2's interaction with ACE2 receptors. Combining DPP4 inhibitors and spironolactone may mitigate COVID-19 complications and infections without adverse side effects.

SourceBentham Science Publishers·JournalEndocrine Metabolic & Immune Disorders - Drug Targets·TypeSystematic review·DateFeb 27, 2022

Researchers call for a patient-centered approach to treating obesity

A recent commentary argues that treating obesity should prioritize compassionate care and focus on health rather than weight. The researchers aim to eliminate the false dichotomy between eating and weight disorders, promoting a patient-centered approach that screens for and addresses eating disorders throughout treatment.

SourceUniversity at Buffalo·JournalJournal of the Academy of Nutrition and Dietetics·TypeCommentary/editorial·DateFeb 24, 2022

Does severe COVID-19 affect pregnancy outcomes?

A recent study published in Acta Obstetricia et Gynecologica Scandinavica has found that severe COVID-19 in pregnancy is associated with a higher risk of adverse outcomes, including preterm birth and stillbirths. The research highlights the importance of vaccination against severe disease to protect both mothers and babies.

SourceWiley·JournalActa Obstetricia Et Gynecologica Scandinavica·DateFeb 24, 2022

Anti-tumor drug promotes weight loss in mice

A new study found that an anti-tumor drug, camptothecin, can activate a natural hunger-suppressing pathway in mice, leading to significant weight loss. The mechanism involves the elevation of growth differentiation factor 15 (GDF15), which suppresses food intake and reduces body weight.

SourcePLOS·JournalPLOS Biology·TypeExperimental study·DateFeb 24, 2022

A study in which UNEATLANTICO participated, led by Dr. Cubas, demonstrates the benefits of nut consumption in the elderly

A study led by Dr. Cubas found that regular nut consumption is associated with a lower prevalence of abdominal obesity and metabolic syndrome in elderly people in northern Spain. The research, published in International Journal of Environmental Research and Public Health, involved 556 participants aged 65-79 years.

SourceUniversidad Europea del Atlantico·JournalInternational Journal of Environmental Research and Public Health·TypeCase study·DateFeb 23, 2022

Obesity may increase end-stage kidney disease risk in women with type 2 diabetes

A new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that obesity may increase the risk of end-stage kidney disease in women with type 2 diabetes. Managing blood pressure and sugar levels is not enough to slow progression, emphasizing the need for weight management.

SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology and Metabolism·DateFeb 22, 2022

Middle-aged men see weight gain as inevitable

A new study reveals that middle-aged men perceive weight gain as an inevitable consequence of family and career commitments. The research found that these men experience low self-worth and despondency, despite awareness of health risks, due to a lack of education on nutrition and lifestyle factors.

SourceAnglia Ruskin University·JournalInternational Journal of Environmental Research and Public Health·TypeSurvey·DateFeb 16, 2022

Gastric bypass is best weight loss option for diabetes patients, study finds

A new study published in JAMA Network Open suggests that gastric bypass surgery is the most effective treatment option for patients with severe obesity and type 2 diabetes, leading to greater weight loss and a higher rate of remission. The study found that gastric bypass produces better results regardless of diabetes severity.

SourceColumbia University Irving Medical Center·JournalJAMA Network Open·TypeComputational simulation/modeling·DateFeb 15, 2022

First get your heart in shape then get pregnant

A new Northwestern Medicine study reveals that more than half of young women in the US have at least one risk factor for poor heart health before pregnancy. Optimizing heart health before and during pregnancy can prevent complications, deliver a healthy baby, and even reduce the risk of heart disease years later.

SourceNorthwestern University·JournalCirculation·DateFeb 14, 2022

Hospital admission with liver cirrhosis: highest mortality rate of all chronic diseases

A nationwide study in Germany found that liver cirrhosis has the highest mortality rate among chronic diseases, with 0.94% of hospital admissions affected. The study also showed a decline in mortality rates due to improvements in Hepatitis C treatment, but an increase in non-alcoholic fatty liver disease cases.

SourceGoethe University Frankfurt·JournalThe Lancet Regional Health - Europe·TypeObservational study·DateFeb 11, 2022

Obesity may increase risk of some female reproductive disorders

A study published in PLOS Medicine found associations between obesity and various female reproductive conditions. Researchers used Mendelian randomization to investigate causal links between body mass index, waist-to-hip ratio, and risk of conditions like uterine fibroids and pre-eclampsia.

SourcePLOS·JournalPLOS Medicine·TypeObservational study·DateFeb 1, 2022

Connection to racial identity may boost body image in Black youth

A new Penn State study found that Black youth with high BMIs reported fewer weight concerns when they had a strong sense of racial identity. Fathers also played a role in shaping their daughters' body image, particularly when involved in teaching about Black culture. The findings suggest that services promoting youth racial identity an...

SourcePenn State·JournalJournal of Research on Adolescence·TypeObservational study·DateJan 25, 2022

How can body weight affect the mortality risk of excessive drinkers?

A recent study published in Drug and Alcohol Dependence found that people with underweight who drink excessively may be at an even higher risk of dying from heart disease, cancer, and other causes. The researchers analyzed data on mortality risk among drinkers and non-drinkers using the CDC categories to define

SourcePenn State·JournalDrug and Alcohol Dependence·TypeObservational study·DateJan 24, 2022

Scientists dive deep into the different effects of morning and evening exercise

A comprehensive study of exercise performed at different times of the day has identified distinct health-promoting signaling molecules produced by the body in an organ-specific manner. The findings suggest that exercising at the right time can optimize health benefits, particularly for individuals at risk of obesity and type 2 diabetes.

SourceUniversity of Copenhagen - The Faculty of Health and Medical Sciences·JournalCell Metabolism·TypeExperimental study·DateJan 14, 2022

Chewing to stay slim: how to savor your food better and dodge weight gain, too!

A recent study published in Scientific Reports found that chewing food thoroughly increases energy expenditure through diet-induced thermogenesis (DIT), which helps prevent obesity. The study involved participants who chewed liquid food for varying durations, revealing that prolonged chewing and tasting increased DIT, gas exchange, pro...

SourceWaseda University·JournalScientific Reports·TypeExperimental study·DateJan 12, 2022

Association of weight loss surgery with severity of COVID-19

A study of nearly 12,000 obese patients found that substantial weight loss achieved through weight loss surgery was associated with improved outcomes after contracting COVID-19, including lower risk of severe disease. The results suggest that weight loss surgery may help mitigate the severity of COVID-19 in individuals with obesity.

SourceJAMA Network·JournalJAMA Surgery·DateDec 29, 2021

Diabetes drug from the group of SGLT2 inhibitors normalizes insulin action in the brain

Researchers found that SGLT2 inhibitor empagliflozin can improve insulin sensitivity in the brain, leading to better glucose control and reduced liver fat content. This breakthrough discovery positions SGLT2 inhibitors as a potential treatment for insulin resistance in the brain.

SourceDeutsches Zentrum fuer Diabetesforschung DZD·JournalDiabetes Care·TypeRandomized controlled/clinical trial·DateDec 20, 2021